Melqart Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.8M | Buy |
1,326,719
+327,272
| +33% | +$10.8M | 6.26% | 5 |
|
|
2025
Q1 | $40.2M | Sell |
999,447
-136,987
| -12% | -$5.51M | 5.24% | 6 |
|
|
2024
Q4 | $53.5M | Sell |
1,136,434
-75,824
| -6% | -$3.57M | 6.45% | 4 |
|
|
2024
Q3 | $64M | Sell |
1,212,258
-463,527
| -28% | -$24.5M | 5.79% | 5 |
|
|
2024
Q2 | $90.8M | Buy |
1,675,785
+692,390
| +70% | +$37.5M | 7.51% | 1 |
|
|
2024
Q1 | $68.9M | Buy |
+983,395
| New | +$68.9M | 4.3% | 5 |
|